Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Caniglia

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Recenti Progressi in Medicina|January 1, 1985
[Anti-collagen IV antibodies in patients with scleroderma and idiopathic Raynaud's phenomenon]A Gabrielli, M Montroni, S Rupoli, et al.
Clinical and Experimental Immunology|December 1, 1991
Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopesA Gabrielli, M Candela, A M Ricciatti, et al.
Transplantation Proceedings|August 19, 2007
The registry of brain deaths in quality control program: evaluation of potentiality of each hospital in Abruzzo and Molise regionsD Maccarone, I Parzanese, N Torlone, et al.
Transplantation Proceedings|June 8, 2006
Organ donation quality control in Abruzzo region (Italy)I Parzanese, D Maccarone, L Caniglia, et al.
Arthritis and Rheumatism|November 1, 1988
A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenonA Gabrielli, M Montroni, S Rupoli, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1994
Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patientsA Manzin, M Candela, S Paolucci, et al.
F1000Research|October 22, 2020
Immunopathology of galectin-3: an increasingly promising target in COVID-19John L Caniglia, Swapna Asuthkar, Andrew J Tsung, et al.
Transplantation Proceedings|June 8, 2006
Risk factors that can influence kidney transplant outcomeI Parzanese, D Maccarone, L Caniglia, et al.
Peerj|June 27, 2020
A potential role for Galectin-3 inhibitors in the treatment of COVID-19John L Caniglia, Maheedhara R Guda, Swapna Asuthkar, et al.
Clinical and Experimental Immunology|July 1, 1994
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemiaA Gabrielli, A Manzin, M Candela, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|January 1, 1985
[Anti-collagen IV antibodies in patients with scleroderma and idiopathic Raynaud's phenomenon]A Gabrielli, M Montroni, S Rupoli, et al.
Clinical and Experimental Immunology|December 1, 1991
Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopesA Gabrielli, M Candela, A M Ricciatti, et al.
Transplantation Proceedings|August 19, 2007
The registry of brain deaths in quality control program: evaluation of potentiality of each hospital in Abruzzo and Molise regionsD Maccarone, I Parzanese, N Torlone, et al.
Transplantation Proceedings|June 8, 2006
Organ donation quality control in Abruzzo region (Italy)I Parzanese, D Maccarone, L Caniglia, et al.
Arthritis and Rheumatism|November 1, 1988
A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenonA Gabrielli, M Montroni, S Rupoli, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1994
Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patientsA Manzin, M Candela, S Paolucci, et al.
F1000Research|October 22, 2020
Immunopathology of galectin-3: an increasingly promising target in COVID-19John L Caniglia, Swapna Asuthkar, Andrew J Tsung, et al.
Transplantation Proceedings|June 8, 2006
Risk factors that can influence kidney transplant outcomeI Parzanese, D Maccarone, L Caniglia, et al.
Peerj|June 27, 2020
A potential role for Galectin-3 inhibitors in the treatment of COVID-19John L Caniglia, Maheedhara R Guda, Swapna Asuthkar, et al.
Clinical and Experimental Immunology|July 1, 1994
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemiaA Gabrielli, A Manzin, M Candela, et al.
Pageof 2